Rick Carpenter - 15 Aug 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role: Chief Technology Officer
Signature: /s/ Rachel Malina, Attorney-in-Fact for Rick A. Carpenter
Issuer symbol: TNDM
Transactions as of: 15 Aug 2024
Net transactions value: -$31,813
Form type: 4
Filing time: 19 Aug 2024, 20:31:41 UTC
Previous filing: 20 Jun 2024
Next filing: 18 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNDM	Common Stock	Options Exercise	$0	+596	+5.3%	$0.000000	11,832	15 Aug 2024	Direct
transaction	TNDM	Common Stock	Tax liability	$9,334	-213	-1.8%	$43.82	11,619	15 Aug 2024	Direct	F1
transaction	TNDM	Common Stock	Options Exercise	$0	+1,437	+12%	$0.000000	13,056	15 Aug 2024	Direct
transaction	TNDM	Common Stock	Tax liability	$22,480	-513	-3.9%	$43.82	12,543	15 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNDM	Restricted Stock Unit	Options Exercise	$0	-596	-25%	$0.000000	1,787	15 Aug 2024	Common Stock	596		Direct	F2, F3, F4
transaction	TNDM	Restricted Stock Unit	Options Exercise	$0	-1,437	-12%	$0.000000	10,060	15 Aug 2024	Common Stock	1,437		Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2	Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F3	Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4	RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
F5	Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F6	Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F7	RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.